Anzeige
Mehr »
Login
Freitag, 08.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MUW9 | ISIN: SG1V07936171 | Ticker-Symbol: N/A
1-Jahres-Chart
CHINA XLX FERTILISER LTD Chart 1 Jahr
5-Tage-Chart
CHINA XLX FERTILISER LTD 5-Tage-Chart
ACCESSWIRE
183 Leser
Artikel bewerten:
(1)

China XLX Fertiliser: China XLX Announces 2024 First Three Quarters Results

Finanznachrichten News

China XLX's Profit for 9M 2024 Surged by 80% YoY

Efforts in Efficiency Enhancement, Cost Reduction and Resources Optimization
Produced Remarkable Results

Results highlights for first three quarters in 2024:

  • Net profit climbed 75.8% YoY to RMB 2.031 billion.

  • Net profit attributable to owners of the parent company surged 80.7% YoY to RMB 1.534 billion.

  • Basic earnings per share grew 85.3% YoY to RMB 1.26.

  • Financial position continued to improve with the gearing ratio dropped to 59.4%.

HONG KONG, CHINA / ACCESSWIRE / October 31, 2024 / China XLX Fertiliser Ltd. ("China XLX" or the "Company", together with its subsidiaries collectively known as the "Group") (HKSE: 01866.HK) announced that the Group's revenue for the nine months ended 30 September 2024 (the "Period") amounted to approximately RMB 17.42 billion. Net profit increased by 75.8% YoY to approximately RMB 2.031 billion. Net profit attributable to owners of the parent company surged by 80.7% YoY to RMB 1.534 billion.

In the first three quarters of 2024, benefiting from the decline in feedstock costs and the stable operation of production, the Group's gross profit grew by 5% YoY. Through effective cost management, its administrative expenses and financial expenses decreased by 2% and 13% respectively. In addition, the disposal of Tianxin Coal generated an investment gain of approximately RMB 790 million. The above factors led to a significant increase in the Group's net profit. In this regard, the Group completed the capital increase in its non-wholly owned subsidiaries and enlarged its shareholding to 80.18%, leading to a significant increase in the net profit attributable to the parent company.

As the global economy gradually picked up, the market demand for the Group's main products remained stable. Although fluctuations in raw material prices weighed on the product prices, the Group achieved stable improvement in its operating results by expanding production capacity and sales channels. The sales revenue of fertiliser segment, chemical segment, gas segment and medical intermediate accounted for 60%, 36%, 2% and 2% respectively of the total revenue.

During the Period, the sales volume of urea products increased by 33% YoY to 2.768 million tons mainly due to the expansion of production capacity and resumed operation of some production facilities. Meanwhile, with stepped-up efforts to promote high-efficiency compound fertilisers and differentiated fertilisers, the overall gross profit margin of compound fertilizers increased by 5% YoY. Underpinned by the economic recovery, the demand for methanol recovered and its sales volume for the period increased by 17% YoY, and the gross profit margin increased by 8% YoY.

The Group flexibly adjusted its production capacity and bolstered production efficiency to further meet the needs of downstream manufacturing industries. Although the price of melamine decreased by 8% YoY due to the weakness of real estate market, its sales volume increased by 9% YoY as the Group explored the international market, leading to an increase in the export volume (especially Turkey).

In the first three quarters of 2024, with the support of technological improvement and stable equipment operation, the sales volume of DMF increased by 33% YoY. In terms of the pharmaceutical intermediate segment, the Group optimized the product structure and increased the proportion of sales of high value-added products, with its average selling price increasing by 18% YoY.

Looking ahead into the future, Mr. Liu Xingxu, Chairman of China XLX , said: The fourth quarter will see the peak demand season for winter. With the support of macroeconomic policies, the price of coal feedstock is expected to stabilize and rebound, forming effective support for fertiliser prices. Meanwhile, with the implementation of environmental protection and production capacity control policies, the supply of nitrogen fertilisers will reduce in stages. Driven by the demand arising from winter fertiliser reserves and off-season procurement, fertiliser prices are expected to gradually stabilize. The Group will continue to promote green and low-carbon transformation through technological innovation and industrial chain extension, thereby enhancing product value and promoting high-quality development.

Mr. Liu Xingxu pointed out that China XLX will leverage its competitive edges in R&D to promote the development of new chemical materials and fine chemicals to meet the market demand for high-performance and high value-added products and ensure the Group's sustainable growth in the long run. Through optimizing the product structure and improving resource utilization efficiency, the Group will sharpen its competence and achieve it sustainable development goals.

~ END ~

About China XLX Fertiliser Ltd.

China XLX Fertiliser Ltd. is one of the largest and most cost-efficient coal-based urea producers in China. It is principally engaged in developing, manufacturing and selling of urea, compound fertiliser, methanol, dimethyl ether, melamine, furfuryl alcohol, furfural, 2-methylfuran, pharmaceutical intermediates and related differentiated products. The Group adheres to the development strategy of "maintaining overall cost leadership and creating competitive differentiation" while strengthening the core fertiliser operations. With support of the resources in Xinxiang, Xinjiang and Jiangxi, it extends the value chain to upstream new energy and new materials and diversifies into coal chemical related products. The Company's shares (stock code: 01866.HK) are traded on the main board of the Hong Kong Stock Exchange.

Investor and Media Enquiries

China XLX Fertiliser Ltd.
Gui Lin
Tel: 86-135-6942-3415
Email: gui.lin@chinaxlx.com.hk

PRChina Limited
Rachel Chen
Tel: 852-2522 1368 / 852-2522 1838
Email: rchen@prchina.com.hk



File: Press Release?China XLX Announces 2024 First Three Quarters Results

SOURCE: China XLX Fertiliser



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.